As manufacturers adopt artificial intelligence solutions to enhance efficiency and reduce costs, agentic AI systems present both remarkable opportunities and unique regulatory considerations. There are three key areas manufacturers should consider in order to harness the power of AI while maintaining the quality, safety, and compliance standards that are essential to GMP operations.

AI has emerged as a primary driver of business optimization and innovation within manufacturing, signaling the next phase of digital transformation. Learn how Agentic AI is fundamentally reshaping how processes are designed, executed, and optimized.

Today, manufacturing is experiencing a shift that promises to redefine its very foundations with the critical choice of embracing the wave of technological advancement or risk being left behind in an increasingly competitive landscape. Here's how five pivotal trends are reshaping the future of manufacturing, and why they demand our attention now more than ever.

Deciding what to digitize in an MES solution or recipe can be overwhelming. So exactly what data matters most? Our Apprentice team recently worked with other vendors and biomanufacturers in the BioPhorum MES of the Future workstream to define what data is the most important and most common to capture, manage, and structure in an MES. Read on for expert insights.

While on-prem MES solutions appear to offer control and customization, they come with significant risks related to cost, scalability, maintenance, security, and the ability to adapt to new technologies and business needs.

While the road to enterprise-wide system adoption is undeniably complex – from establishing a robust global infrastructure, to ensuring iron-clad cyber-security, and driving value through adoption while managing the change – it’s not impossible. Read on to learn the three main requirements for scaling globally, quickly and thoughtfully.

In today's fast-paced manufacturing environment, businesses face increasing pressure to optimize operations, reduce costs, and maintain high-quality standards. While traditional on-premises Manufacturing Execution Systems (MES) once served as an essential tool for managing production processes, the advent of new technology combined with new therapeutic innovations has introduced the need for modern, SaaS-based MES platforms.

The food and beverage industry is poised for significant forward momentum, driven significantly by innovation. As manufacturers focus on how their facilities and the processes they carry out can become more efficient, predictable, and sustainable, there will be greater adoption of end-to-end manufacturing technologies that can help reduce costs, consolidate resources, and drive growth through process improvement.

Changing market dynamics, an industry push toward innovation, and customer requests for greater transparency are creating the "perfect storm." Adopting new technology shouldn’t be viewed as a way to simply brave the storm but rather a lighthouse to guide CDMOs to a new horizon.

From the acronym soup of RFP’s, URS’s, MOM vs MES, and CFR Part 11 to budgeting, negotiations, stakeholder misalignments and long buying cycles: MES evaluations are just hard. Thus, many are wary of starting the journey. Take these 5 steps before you start the journey to reduce these pains.

Starting your digital journey does not need to be scary if you take it one step at a time. Start small to produce outsized returns all while working towards a fully digital manufacturing strategy.

From greater efficiency and productivity to process optimization, here are the most valuable Tempo MES features responsible for enhancing connectivity and enabling agile responses to market demands.

Digitizing your pharmaceutical manufacturing processes offers a range of benefits that can significantly enhance efficiency, compliance, and overall effectiveness. Here we explore five compelling reasons to consider making the move this year.

Learn 10 top trends shaping the future of pharma and how organizations can adapt to stay on budget and ahead of the curve.

The security of IoT networks and the integrity of the data they provide are foundational to the success of AI implementation within pharma. Here we examine the role of AI, IoT, and the urgent need for investment in cybersecurity.

Still don’t have a clear understanding of what an MES Lite is, or if you need it? Keep reading as we break down the essentials, options, and benefits.

Learn the top 10 trends shaping the future of pharma and how organizations can adapt to stay on budget and ahead of the curve.

Manufacturing Execution Systems (MES) are a well-established software used to transform raw materials into a finished drug product. Times have evolved, and if this vital system is no longer performing as it once did, it may be time to contemplate a change. We’ll help you identify if that time is now.

Apprentice Co-Founder & CEO, Angelo Stracquatanio, shares his vision for Tempo today and in the future. He speaks to why this release is our most important yet, and how it deepens our robust commercial capabilities — as well as how they can be leveraged across multiple sites.

Read the June 2023 BioPhorum report, “Risk considerations for the implementation of extended reality solutions within a GxP environment in the biopharma industry.”